Introduction to the Phreesia Class Action Lawsuit The Phreesia class action lawsuit seeks to represent purchasers or acquirers of Phreesia, Inc. (NYSE: PHR) common stock between May 8, 2025 and March 30, 2026, inclusive (the “Class Period”).  Captioned Theodoulou v. Phreesia, Inc., No. 26-cv-00556 (D. Del.), the Phreesia class action lawsuit charges Phreesia and certain of Phreesia’s top executive officers with violations of the

Introduction to the AeroVironment Class Action Lawsuit The AeroVironment class action lawsuit seeks to represent purchasers or acquirers of AeroVironment, Inc. (NASDAQ: AVAV) securities between June 25, 2025 and March 10, 2026, inclusive (the “Class Period”).  Captioned Norrell v. AeroVironment, Inc., No. 26-cv-01429 (E.D. Va.), the AeroVironment class action lawsuit  charges AeroVironment and certain of AeroVironment’s top current and former executive officers with violations

Introduction to a Dupixent Cancer Lawsuit in Tennessee Welcome to this authoritative guide by a Tennessee Dupixent Cancer Lawyer on a Dupixent Cancer Lawsuit in Tennessee. Dupixent (dupilumab) has become a widely used biologic therapy for chronic inflammatory conditions, particularly moderate to severe atopic dermatitis (eczema), asthma with an eosinophilic phenotype, and chronic rhinosinusitis with nasal polyps. As its use

Introduction to Securities Class Action Lawsuits Securities class action lawsuits remain one of the most consequential forms of corporate litigation in U.S. capital markets. They sit at the intersection of disclosure obligations, investor protection, market integrity, and corporate governance These lawsuits also impose real operating costs on companies, including legal spend, executive distraction, reputational harm, and significant settlement payments funded